Journal Of Cardiovascular Translational Research Will Bridge Gap Between Biomedical Research And Clinical Medicine

Main Category: Cardiovascular / Cardiology
Also Included In: Biology / Biochemistry;  Genetics
Article Date: 06 Feb 2008 - 4:00 PDT

email to a friend   printer friendly   view / write opinions   rate article

Springer and the International Society for Cardiovascular Translational Research (ISCTR) are founding a new, quarterly biomedical publication called the Journal of Cardiovascular Translational Research (JCTR). The journal will be officially introduced at the Inaugural Meeting of the International Society for Cardiovascular Translational Research to be held 9 -10 February 2008 in San Diego, CA, USA. The first issue will be published in March 2008.

The Journal of Cardiovascular Translational Research will publish original papers in the areas of cellular therapy, genomics, personalized medicine and devices for the potential treatment of advanced cardiovascular disease. The aim of the journal is to provide outstanding peer-reviewed articles with implications for the current and future practice of clinical cardiovascular medicine. It will provide content in which translational research involving multiple disciplines such as genetics, proteomics, epidemiology and preclinical and clinical research is used interchangeably within a study to advance the understanding of disease or response to treatment. Editors-in-chief Nabil Dib of the University of California at San Diego and Jennifer L. Hall of the University of Minnesota are supported by outstanding executive and editorial boards.

Nabil Dib, MD, MSc, co-editor-in-chief of JCTR, said, "Cardiovascular disease kills some 17 million people every year, which is one-third of all deaths worldwide. Groundbreaking developments in this area between biomedical research and clinical medicine necessitate a new platform for the exchange and dissemination of information. Springer, as an international STM publisher, is in a strong position to launch this new journal."

Aaron Johnson, Editor, Biomedical Engineering, Biotechnology and Genetics at Springer, said, "Currently there is no journal in this field that provides a forum between 'bench and bedside'. JCTR will fill this gap, presenting a critical overview of advances as they unfold. We are excited at the prospect of working with the ISCTR on this new journal, which can help to shape the future of cardiovascular research."

----------------------------
Article adapted by Medical News Today from original press release.
----------------------------

The mission of the International Society for Cardiovascular Translational Research (http://www.isctr.org/) is to provide an environment for collaboration and guidance among basic and clinical scientists to expedite scientific discoveries into clinical application. ISCTR is also committed to listening to the community and fostering outreach and education programs to make the ever expanding body of genetic research and clinical trials available to the general public.

Springer (http://www.springer.com/) is the second-largest publisher of journals in the science, technology, and medicine (STM) sector and the largest publisher of STM books. It publishes on behalf of more than 300 academic associations and professional societies. Springer is part of Springer Science+Business Media, one of the world's leading suppliers of scientific and specialist literature. The group publishes over 1,700 journals and more than 5,500 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in over 20 countries in Europe, the USA, and Asia, and some 5,000 employees.

Journal of Cardiovascular Translational Research: ISSN 1937-5387 (print) 1937-5395 (electronic)

Source: Joan Robinson
Springer